PROCEPT BioRobotics (PRCT) Stock: Buy, Sell, or Hold?
PRCT - PROCEPT BioRobotics Corporation Common Stock
$17.16
0.14 (0.82%)
▲
5d:
-0.23%
30d:
-21.89%
90d:
-19.09%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 03, 2026
30d
Get Alerted When PRCT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PRCT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PRCT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PRCT is currently trading at $17.16, which is considered oversold relative to its 30-day fair value range of $18.09 to $21.37.
Technical Outlook: Technically, PRCT is in a strong downtrend. The price is currently testing key support at $16.74. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PRCT scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $21.64 (+26.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PRCT is in a strong downtrend. The price is currently testing key support at $16.74. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PRCT scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $21.64 (+26.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$18.09 -
$21.37
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 26.1% below Wall St target ($21.64)
- CAUTION: Bottoming setup, but lagging the sector by 34% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$18.09 -
$21.37
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$16.74
Resistance Level
$19.38
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.88
Wall Street Target
$21.64
(+26.1%)
Revenue Growth (YoY)
19.3%
Profit Margin
-32.5%
Share & Embed Analysis
Last updated: October 03, 2026 5:26 PM ET
Data refreshes hourly during market hours. Next update: 6:26 PM
Data refreshes hourly during market hours. Next update: 6:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRCT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 64 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 51 HOLD |
|
GKOS
Glaukos Corp |
STRONG BUY
15 analysts |
$199 | 72 BUY |
